|
1
|
Stracke ML, Krutzsch HC, Unsworth EJ, et
al: Identification, purification, and partial sequence analysis of
autotaxin, a novel motility-stimulating protein. J Biol Chem.
267:2524–2529. 1992.PubMed/NCBI
|
|
2
|
Umezu-Goto M, Kishi Y, Taira A, et al:
Autotaxin has lysophospholipase D activity leading to tumor cell
growth and motility by lysophosphatidic acid production. J Cell
Biol. 158:227–233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tokumura A, Majima E, Kariya Y, et al:
Identification of human plasma lysophospholipase D, a
lysophosphatidic acid-producing enzyme, as autotaxin, a
multifunctional phosphodiesterase. J Biol Chem. 277:39436–39442.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kehlen A, Englert N, Seifert A, Klonisch
T, Dralle H, Langner J and Hoang-Vu C: Expression, regulation and
function of autotaxin in thyroid carcinomas. Int J Cancer.
109:833–838. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saunders LP, Ouellette A, Bandle R, et al:
Identification of small-molecule inhibitors of autotaxin that
inhibit melanoma cell migration and invasion. Mol Cancer Ther.
7:3352–3362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Debies MT and Welch DR: Genetic basis of
human breast cancer metastasis. J Mammary Gland Biol Neoplasia.
6:441–451. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang SY, Lee J, Park CG, et al: Expression
of autotaxin (NPP-2) is closely linked to invasiveness of breast
cancer cells. Clin Exp Metastasis. 19:603–608. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Panupinthu N, Lee HY and Mills GB:
Lysophosphatidic acid production and action: critical new players
in breast cancer initiation and progression. Br J Cancer.
102:941–946. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Y, Mou Lj, Liu N, et al: Autotaxin
expression in non-small cell lung cancer. Am J Respir Cell Mol
Biol. 21:216–222. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stassar MJ, Devitt G, Brosius M, et al:
Identification of human renal cell carcinoma associated genes by
suppression subtractive hybridization. Br J Cancer. 85:1372–1382.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deissler H, Blass-Kampmann S, Bruyneel E,
et al: Neural cell surface differentiation antigen gp130(RB13-6)
induces fibroblasts and glioma cells to express astroglial proteins
and invasive properties. FASEB J. 13:657–666. 1999.
|
|
12
|
Zhang G, Zhao Z, Xu S, et al: Expression
of autotoxin mRNA in human hepatocellular carcinoma. Chin Med J
(Engl). 112:330–332. 1999.PubMed/NCBI
|
|
13
|
Chen Y, Wei X, Guo C, et al: Runx3
suppresses gastric cancer metastasis through inactivation of MMP9
by upregulation of TIMP-1. Int J Cancer. 129:1586–1598. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong M, Meng L, Jiang B, et al: p37 from
mycoplasma hyorhinis promotes cancer cell invasiveness and
metastasis through activation of MMP-2 and followed by
phosphorylation of EGFR. Mol Cancer Ther. 7:530–537. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schwartz GK: Invasion and metastases in
gastric cancer: in vitro and in vivo models with clinical
correlations. Semin Oncol. 23:316–324. 1996.PubMed/NCBI
|
|
16
|
Yasui W, Oue N, Aung PP, Matsumura S,
Shutoh M and Nakayama H: Molecular-pathological prognostic factors
of gastric cancer: a review. Gastric Cancer. 8:86–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Euer N, Schwirzke M, Evtimova V, et al:
Identification of genes associated with metastasis of mammary
carcinoma in metastatic versus non-metastatic cell lines.
Anticancer Res. 22:733–740. 2002.PubMed/NCBI
|
|
18
|
Nam SW, Clair T, Campo CK, et al:
Autotaxin (ATX), a potent tumor mitogen, augments invasive and
metastatic potential of ras-transformed cells. Oncogene.
19:241–247. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kishi Y, Okudaira S, Tanaka M, et al:
Autotaxin is overexpressed in glioblastoma multiforme and
contributes to cell motility of glioblastoma by converting
lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem.
281:17492–17500. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tanaka M, Okudaira S, Kishi Y, et al:
Autotaxin stabilizes blood vessels and is required for embryonic
vasculature by producing lysophosphatidic acid. J Biol Chem.
281:25822–25830. 2006. View Article : Google Scholar
|
|
21
|
Noh JH, Ryu SY, Eun JW, et al:
Identification of large-scale molecular changes of Autotaxin(ENPP2)
knock-down by small interfering RNA in breast cancer cells. Mol
Cell Biochem. 288:91–106. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li X and Lim B: RhoGTPases and their role
in cancer. Oncol Res. 13:323–331. 2003.
|
|
23
|
Bell CH, Aricescu AR, Jones EY and Siebold
C: A dual binding mode for RhoGTPases in plexin signalling. PLoS
Biol. 9:e10011342011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lazer G and Katzav S: Guanine nucleotide
exchange factors for RhoGTPases: good therapeutic targets for
cancer therapy? Cell Signal. 23:969–979. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reymond N, Riou P and Ridley AJ: Rho
GTPases and cancer cell transendothelial migration. Methods Mol
Biol. 827:123–142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wiercinska E, Naber HP, Pardali E, van der
Pluijm G, van Dam H and ten Dijke P: The TGF-β/Smad pathway induces
breast cancer cell invasion through the up-regulation of matrix
metalloproteinase 2 and 9 in a spheroid invasion model system.
Breast Cancer Res Treat. 128:657–666. 2011.
|
|
27
|
Kim ES, Kim MS and Moon A: Transforming
growth factor (TGF)-beta in conjunction with H-ras activation
promotes malignant progression of MCF10A breast epithelial cells.
Cytokine. 29:84–91. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chuang MJ, Sun KH, Tang SJ, et al:
Tumor-derived tumor necrosis factor-alpha promotes progression and
epithelial-mesenchymal transition in renal cell carcinoma cells.
Cancer Sci. 99:905–913. 2008. View Article : Google Scholar
|
|
29
|
Jiang WG, Raz A, Douglas-Jones A and
Mansel RE: Expression of autocrine motility factor (AMF) and its
receptor, AMFR, in human breast cancer. J Histochem Cytochem.
54:231–241. 2006. View Article : Google Scholar : PubMed/NCBI
|
